Scholar Rock Holding buy BiotechBee
Start price
13:51
/
50%
€8.40
Target price
31.01.27
€11.00
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 31.01.27. The prediction end date can be changed by BiotechBee at any time.Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Scholar Rock Holding | - |
| iShares Core DAX® | -3.429% |
| iShares Nasdaq 100 | -6.121% |
| iShares Nikkei 225® | -7.364% |
| iShares S&P 500 | -4.366% |
According to BiotechBee what are the pros and cons of Scholar Rock Holding for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year